Prognostic value of serum hepatocyte growth factor in patients with acute coronary syndromes

Japanese Circulation Journal

Volumn 63, Issue 8, 1999, Pages 583-588

  Sato, Tetsuya ^a,c   Yoshinouchi, Takeo ^a   Sugimoto, Taro ^a   Sakamoto, Taisuke ^a   Fujieda, Hiroyuki ^a   Murao, Satoshi ^a   Sato, Hirohiko ^a   Ohe, Tohru ^b  

^a Matsuyama Shimin Hospital   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c MATSUYAMA SHIMIN HOSPITAL   (Japan)

Author keywords

Acute coronary syndromes; Adverse events; Heparin; Hepatocyte growth factor; Prognostic value

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; HEPARIN; ISOSORBIDE DINITRATE; SCATTER FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PROGNOSIS; SERUM; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; AGED; ANGINA PECTORIS; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLEEDING TIME; BLOOD COAGULATION; CORONARY DISEASE; CREATINE KINASE; ENDOTHELIUM; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET COUNT; PROGNOSIS; TIME FACTORS;

EID: 0032777233     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.583     Document Type: Article

References (25)

1. Nakamura T, Nawa K, Ichihaa A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459
2. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C: Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993; 123: 223-235
3. Ono K, Matsumori A, Shioi T, Furukawa U, Sasayama S: Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model. Circulation 1997; 95: 2552-2558
4. Matsumori A, Ono K, Furukawa Y, Okada M, Sasayama S: Circulating hepatocyte growth factor as an early marker of arterial thrombus formation. Jpn Circ J 1998; 62: 311-313
5. Sato T, Yoshinouchi T, Sakamoto T, Fujieda H, Murao S, Ohe T, et al: Hepatocyte growth factor (HGF): a new biochemical marker for acute myocardial infarction. Heart Vessels 1997; 12: 241-246
6. Matsumoto K, Tajima H, Okazaki H, Nakamura T: Heparin as an inducer of hepatocyte growth factor. J Biochem 1993; 114: 820-826
7. Arakaki N, Kawakami S, Nakamura O, Ohnishi T, Miyazaki H, Ishii T, et al: Evidence for the presence of an inactive precursor of human hepatocyte growth factor in plasma and sera of patients with liver diseases. Hepatology 1996; 22: 1728-1734
8. Matsumori A, Ono K, Okada M, Miyamoto T, Sato Y, Sasayama S: Immediate increase in circulating hepatocyte growth factor/scatter factor by heparin. J Mol Cell Cardiol 1998; 30: 2145-2149
9. Raboudi N, Julian J, Rohde LH, Carson DD: Identification of cell-surface heparin/heparan sulfate-binding proteins of a human uterine epithelial cell line (RL95). J Biol Chem 1992; 267: 11930-11939
10. Bussolino F, Renzo MF, Ziche E, Bocchietto E, Olivero M, Naldini L, et al: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-641
11. Giordano S, Ponzetto C, Di Renzo MF, Cooper CS, Rosa C, Comoglio PM: Tyrosine kinase receptor indistinguishable from the c-met protein. Nature 1989a; 339: 155-156
12. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 242-250
13. Heimark RL, Twardzik DR, Schwartz SM: Inhibition of endothelial regeneration by type-beta transforming factor from platelets. Science 1986; 232: 61-65
14. Schaper W, Kubin T: Is hepatocyte growth factor a protein with cardioprotective activity in the ischemic heart? Circulation 1997; 95: 2471-2472
15. Morishita R, Higaki J, Hayashi SI, Yo Y, Aoki M, Nakamura S, et al: Role of hepatocyte growth factor in endothelial regulation: preven-tion of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor. Diabetologia 1997; 40: 1053-1061
16. Matsumoto K, Nakamura T: Emerging multiponent aspects of hepatocyte growth factor. J Biochem 1996; 119: 591-600
17. Sato T, Fujieda H, Murao S, Sato H, Takeuchi T, Ohtsuki Y: Sequential changes of hepatocyte growth factor in the serum and enhanced c-Met expression in the myocardium in a human acute myocardial infarction. Jpn Circ J 1999 (in press)
18. Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Engl J Med 1992; 326: 310-318
19. Woolf N, Davies MJ: Interrelationship between atherosclerosis and thrombosis. In: Fuster V, Verstraete M, editors. Thrombosis in cardiovascular disorders. Philadelphia: WB Saunders, 1992: 41-77
20. Tsubouchi H, Nitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, et al: Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 41-45
21. Weitz JI, Hudoba M, Massel D, Maraganore J, Hirsh J: Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 1990; 86: 385-391
22. Berk BC, Taubman MB, Cragoe EJ Jr, Fenton JW Griendling KK: Thrombin signal transduction mechanisms in rat vascular smooth muscle cells. J Biol Chem 1990; 265: 17334-17340
23. Sato T, Yoshinouchi T, Sugimoto T, Sakamoto T, Fujieda H, Ohe T, et al: Significance of hepatocyte growth factor measurement in acute myocardial infarction (in Japanese). J Cardiol 1998; 32: 77-82
24. Seko Y, Imai Y, Suzuki S, Kamijukkoku S, Hayasaki K, Sakomura Y, et al: Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci 1997; 92: 453-454
25. Tiefenbacher CP, Chilian WM: Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovasc Res 1997; 34: 411-417